产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
CAS No. |
81907-62-2 |
|---|---|
英文名称 |
(2R,6R)-6-((5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid |
别名 |
(25R)-7β,15α-Dihydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oic acid;Aids070759;Aids-070759;Lanost-8-en-26-oic acid, 7,15-dihydroxy-3,11,23-trioxo-, (7.beta.,15.alpha.,25R)-;(7beta,15alpha,25R)-7,15-Dihydroxy-3,11,23-trioxo-lanost-8-en-26-oic acid;GANODERIC ACID A(P);GANODERIC ACID A;(25R)-7β,15α-Dihydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oicaci |
标准英文名 |
(2R,6R)-6-((5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid |
分子式 |
C30H44O7 |
分子量 |
516.67 |
精确分子量 |
516.31 |
SMILES |
C[C@H](CC(=O)C[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O)C(=O)O |
标准SMILES |
CC1(C)[C@@H]2C[C@H](O)C3=C(C(=O)C[C@]4(C)[C@H](C[C@H](O)[C@]43C)[C@H](C)CC(=O)C[C@@H](C)C(O)=O)[C@@]2(C)CCC1=O |
用途 |
Ganoderic acid A is used for its hypolipidemic, antihypertensive, hepatoprotective, and liver function-regulating effects; it is also employed in content determination, identification, and pharmacological studies. |
InChIKey |
DYOKDAQBNHPJFD-JNTBEZBXSA-N |
|
|
评论 |
|---|